BackgroundNeurofibroma is a rare benign tumor. The isolated presence of such lesions in the preperitoneal space with no evidence of systemic disease has never been reported in the literature.Case presentationA 29-year-old white man presented with a 12 months history of progressive abdominal distension. Clinical examination revealed a bulky hypogastric mass. Abdominal computed tomography and pelvic magnetic resonance imaging showed a large, well defined preperitoneal tumor measuring 18 x 17cm extending in the pelvis. A computed tomography guided biopsy was performed which revealed a neurofibroma. Exploratory laparotomy showed a well encapsulated elastic soft tumor in the preperitoneal space which measured 17 x 18cm and weighted 2 Kg. The tumor was completely excised. No recurrence occurred after one year of follow-up.ConclusionSolitary preperitoneal neurofibroma is an extremely rare benign tumor. Its clinical and radiological signs are nonspecific. Preoperative histology can be useful to guide the surgical approach which is the only curative treatment.
Thyroid cancers are generally rare and represent 1% of head and neck cancers. They count for 5.39% of thyroid tumors. Among them, differentiated carcinomas are the most common, including papillary and vesicular forms. However, there are other thyroid cancers that are very rare, one of them being thyroid adenocarcinoma, which in most cases is a metastasis of lungs, breasts, colon, rectum, prostate or renal cancers. The goal of our study is to report a rare case of primary adenocarcinoma of the thyroid gland and to describe the clinical, histological, and therapeutic aspects. A 42-year-old patient with a history of lobo-isthmectomy in December 2013 for a right thyroid nodule, in the ENT department of the Heinrich Lübké Hospital in Diourbel, whose immediate and early post-operative follow-up was uneventful came back in March 2015, 16 months later, with an anterolateral mass of the neck, at the level of previous surgical site. The mass was hard, measuring 5 cm in its greater axis. Para clinical explorations revealed a recurring tumor. Anatomo-pathological examination after surgical excision resulted in a primary adenocarcinoma of the thyroid gland. Adenocarcinoma is a cancer that rarely occurs in the thyroid gland. It is often a secondary metastasis from another organ. The primary adenocarcinoma in the thyroid makes for a very poor prognosis despite good management. Frequent recurrence or persistence of the tumor are often seen during post-operative follow up.
In this work, we discuss the preliminary results of the effectiveness of the hemorrhoidal artery ligation under control Doppler as a new technique for the treatment of hemorrhoids. We report the results of patients with hemorrhoids we have followed over a period of one year who were treated with HAL Doppler. The intra-and postoperative complications were monitored. Patient follow-up was established on the immediate postoperative period, after one month, six months and one year of evolution. Monitoring parameters were both objective (prolapse) and subjective (pain, discomfort, bleeding, satisfaction). 120 patients, all stages combined, were treated with HAL Doppler. The pain is easily controlled with painkillers. Residual rectal bleeding was noted in 3% of the cases. In addition, there was one case of recurrent prolapse which underwent reoperation. After one month, 86,5% patients were satisfied. The hemorrhoidal artery ligation under control Doppler is an easy technique, well accepted by patients who are increasingly demanding it. It is less invasive, less painful and gives fewer complications. It is not only effective for stage III and IV hemorrhoids for which the effect is spectacular but also for stages I and II symptoms, which can expand its indications.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.